J 2022

A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue

PETR, J., L. HOGEBOOM, P. NIKULIN, E. WIEGERS, G. SCHROYEN et. al.

Základní údaje

Originální název

A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue

Autoři

PETR, J. (276 Německo, garant), L. HOGEBOOM (528 Nizozemské království), P. NIKULIN (276 Německo), E. WIEGERS (528 Nizozemské království), G. SCHROYEN (56 Belgie), J. KALLEHAUGE (208 Dánsko), M. CHMELIK (703 Slovensko), P. CLEMENT (56 Belgie), R. E. NECHIFOR (642 Rumunsko), L. A. FODOR (642 Rumunsko), P. C. D. HAMER (528 Nizozemské království), F. BARKHOF (528 Nizozemské království), C. PERNET (208 Dánsko), M. LEQUIN (528 Nizozemské království), S. DEPREZ (56 Belgie), Radim JANČÁLEK (203 Česká republika, domácí), H. J. M. M. MUTSAERTS (528 Nizozemské království), F. B. PIZZINI (380 Itálie), K. E. EMBLEM (578 Norsko) a V. C. KEIL (528 Nizozemské království)

Vydání

MAGMA Magnetic Resonance Materials in Physics, Biology and Medicine, NEW YORK, Springer-Verlag GmbH, 2022, 1352-8661

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30103 Neurosciences

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.300

Kód RIV

RIV/00216224:14110/22:00125243

Organizační jednotka

Lékařská fakulta

UT WoS

000731201900001

Klíčová slova anglicky

Neuroimaging; Radiotherapy; Chemotherapy; Long-term adverse effects; Cognitive decline

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 31. 3. 2023 12:19, Mgr. Michal Petr

Anotace

V originále

Cancer therapy for both central nervous system (CNS) and non-CNS tumors has been previously associated with transient and long-term cognitive deterioration, commonly referred to as 'chemo fog'. This therapy-related damage to otherwise normal-appearing brain tissue is reported using post-mortem neuropathological analysis. Although the literature on monitoring therapy effects on structural magnetic resonance imaging (MRI) is well established, such macroscopic structural changes appear relatively late and irreversible. Early quantitative MRI biomarkers of therapy-induced damage would potentially permit taking these treatment side effects into account, paving the way towards a more personalized treatment planning. This systematic review (PROSPERO number 224196) provides an overview of quantitative tomographic imaging methods, potentially identifying the adverse side effects of cancer therapy in normal-appearing brain tissue. Seventy studies were obtained from the MEDLINE and Web of Science databases. Studies reporting changes in normal-appearing brain tissue using MRI, PET, or SPECT quantitative biomarkers, related to radio-, chemo-, immuno-, or hormone therapy for any kind of solid, cystic, or liquid tumor were included. The main findings of the reviewed studies were summarized, providing also the risk of bias of each study assessed using a modified QUADAS-2 tool. For each imaging method, this review provides the methodological background, and the benefits and shortcomings of each method from the imaging perspective. Finally, a set of recommendations is proposed to support future research.